Work

Abstract B111: Risk of pancreatitis and autoimmune hepatitis among patients with breast cancer receiving 5-years of aromatase inhibitor therapy vs. tamoxifen

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b111

Authors: Yohannes Haile, Allen Seylani

Institution: University of California, Riverside

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444223

Cites:

Cited by:

Related to: